※ 출처: ClinicalTrials.gov
총 91건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy Carcinoma, Non-small Cell Lung Cancer Biological: nivolumab|Biological: ipilimumab|Drug: cabozantinib|Biological: docetaxel|Biological: ramucirumab|Drug: lucitanib Bristol-Myers Squibb|Clovis Oncology, Inc.|Exelixis|Eli Lilly and Company Phase 1|Phase 2 2021-04-15
2 A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lunch Cancer|Recurrent Non-small Cell Lung Cancer|Metastatic Non-small Cell Lung Cancer Biological: Nivolumab|Biological: Relatlimab|Drug: Carboplatin|Drug: Cisplatin|Drug: Paclitaxel|Drug: Nab-Paclitaxel|Drug: Pemetrexed Bristol-Myers Squibb Phase 2 2021-02-17
3 A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors Hepatocellular Carcinoma|Hepatoma|Liver Cancer, Adult|Liver Cell Carcinoma|Liver Cell Carcinoma, Adult Biological: Nivolumab|Biological: Relatlimab Bristol-Myers Squibb Phase 2 2021-02-04
4 A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) Alzheimer Disease Drug: Gantenerumab Hoffmann-La Roche Phase 3 2021-02-01
5 Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) Endometrial Neoplasms Biological: Pembrolizumab|Drug: Carboplatin|Drug: Paclitaxel|Drug: Placebo for pembrolizumab|Drug: Docetaxel|Drug: Cisplatin|Radiation: External Beam Radiotherapy (EBRT)|Drug: Cisplatin (as radiosensitizer)|Radiation: Brachytherapy Merck Sharp & Dohme Corp.|European Network for Gynaecological Oncological Trial Groups|Gynecologic Oncology Group Phase 3 2021-01-10
6 Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015) Advanced/Metastatic Gastroesophageal Adenocarcinoma Biological: Pembrolizumab|Biological: Lenvatinib|Drug: Oxaliplatin|Drug: Capecitabine|Drug: Leucovorin (or Levoleucovorin)|Drug: 5-FU Merck Sharp & Dohme Corp.|Eisai Inc. Phase 3 2020-12-30
7 A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19 Covid19|SARS-CoV-2 Biological: CVnCoV|Biological: Placebo CureVac AG Phase 2|Phase 3 2020-12-14
8 A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) Multiple Sclerosis Drug: Ocrelizumab|Drug: Antihistamine|Drug: Methylprednisolone Hoffmann-La Roche Phase 3 2020-12-03
9 A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) Multiple Sclerosis Drug: Ocrelizumab|Drug: Antihistamine|Drug: Methylprednisolone Hoffmann-La Roche Phase 3 2020-11-26
10 Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults SARS-CoV-2 Infection Drug: Intramuscular injection|Biological: Intramuscular vaccine Medicago Phase 2|Phase 3 2020-11-19